Péron, J M <br/><br/>
Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity.  [electronic resource] 

 -  Gut  Jan 2007 
 - 107-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0017-5749 
<br/><br/><label>Standard No.: </label>10.1136/gut.2005.083477  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--immunology<br/>Cell Division--immunology<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Female<br/>Fibroblasts--immunology<br/>Flow Cytometry--methods<br/>Genetic Therapy--methods<br/>Immunity, Innate--immunology<br/>Immunohistochemistry--methods<br/>Injections, Intraperitoneal<br/>Interleukin-12--administration & dosage<br/>Macrophages--immunology<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Nitric Oxide--biosynthesis<br/>Pancreatic Neoplasms--genetics<br/>Peritoneal Neoplasms--genetics<br/>Reactive Oxygen Species--metabolism